In addition to ADP-ribosylation systems implicated in bacterial or viral infections, the primary connection between ADP-ribosylation and human health comes from sensitivity of some cancer phenotypes to the inhibition of PARP1 and PARP2. Here, PARP2 is linked to cancer.